Source comparison
CJC-1295 vs HGH Therapy — Which Builds More Muscle?
A 2019 study published in the Journal of Clinical Endocrinology & Metabolism found that synthetic growth hormone administration at therapeutic doses suppressed endogenous GH secretion by 70–85% within 48 hours. The pituitary downregulates when it detects exoge
This comparison does not assign a generated winner or score.
- A 2019 study published in the Journal of Clinical Endocrinology & Metabolism found that synthetic growth hormone administration at therapeutic doses suppressed endogenous GH secretion by 70–85% within 48 hours. The pituitary downregulates when it detects exogenous hormone. CJC-1295, a growth hormone-releasing hormone (GHRH) analog, doesn't trigger that suppression because it works through your body's existing pulse mechanism rather than replacing it. That's not a trivial distinction when you're deciding between protocols that cost $400–$1,200 monthly and carry different regulatory classifications.
- Our team has worked with researchers evaluating both peptide secretagogues and recombinant HGH across preclinical models. The pattern we've observed is consistent: individuals choosing between these compounds rarely understand that one amplifies a biological rhythm while the other replaces it entirely.
- What's the difference between CJC-1295 and HGH therapy?
- CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that binds to GHRH receptors in the anterior pituitary, stimulating endogenous growth hormone secretion in natural pulsatile patterns. Exogenous HGH (recombinant human growth hormone, or rhGH) is bioidentical synthetic hormone administered subcutaneously to replace or supplement the body's natural GH production. CJC-1295 preserves physiological secretion patterns; HGH therapy bypasses them.
- Here's what that distinction actually means: CJC-1295 works within your circadian GH rhythm. Pulses peak during deep sleep, taper during waking hours. HGH therapy creates steady-state serum levels that don't match natural patterns, which changes how IGF-1 (insulin-like growth factor 1) responds downstream. The pulsatile secretion pattern matters for receptor sensitivity. Constant GH exposure can desensitise hepatic IGF-1 receptors over time. This article covers the biological mechanisms that differentiate these compounds, the IGF-1 response curves each produces, and what existing peptide research tells us about preservation of endogenous function.